MTHFR and Methylation: A Practical Guide to the Most Misunderstood Gene Variant in Consumer Nutrigenomics

Roughly forty percent carry at least one MTHFR C677T copy reducing folic acid conversion to active methylfolate. Homozygous carriers retain approximately thirty percent enzyme activity; heterozygous about sixty-five percent. Clinically meaningful for folate metabolism but not the catastrophic dysfunction some communities suggest.

Biochemical Reality

Reduced activity means decreased conversion of synthetic folic acid — in fortified foods and most supplements — into active methylfolate required by the methylation cycle. Carriers may accumulate unmetabolised folic acid while experiencing functional folate insufficiency. Solution: replace synthetic folic acid with pre-formed methylfolate (400-800mcg daily), emphasise dietary natural folate — leafy greens, legumes, liver — ensure adequate B12, B6, riboflavin as cofactors.

Proportionality

The variants are common, effects real but moderate, interventions simple. Online culture's tendency attributing extraordinarily broad symptoms to MTHFR creates anxiety exceeding clinical significance. Having the polymorphism means your folate metabolism benefits from a specific, inexpensive accommodation — not that you're broken. Redirect anxiety energy into foundational behaviours — sleep, movement, whole food, stress management — determining ninety-five percent of outcomes regardless of genotype.